1-(2-chloroethyl)cytosine | 73000-44-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 1-(2-chloroethyl)cytosine
• 英文别名: 1-(2-Chlorethyl)-cytosin；4-amino-1-(2-chloro-ethyl)-1H-pyrimidin-2-one；1-(2-chloroethyl)-4-amino-2-1H-pyrimidinone；4-Amino-1-(2-chloroethyl)pyrimidin-2(1H)-one；4-amino-1-(2-chloroethyl)pyrimidin-2-one
• CAS: 73000-44-9
• 化学式: C₆H₈ClN₃O
• 分子量: 173.602
• InChiKey: TYVGLQADBCWKEI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.5
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  58.7
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  1-(2-chloroethyl)cytosine 在 tris-(dibenzylideneacetone)dipalladium(0) 、 potassium carbonate 、 caesium carbonate 、 2-二环己基磷-2',6'-二异丙氧基-1,1'-联苯 作用下， 以 1,4-二氧六环 、 乙醇 为溶剂， 反应 18.0h， 生成 1-(2-(dimethylamino)ethyl)-4-((4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-5-propionylpyridin-2-yl)amino)pyrimidin-2(1H)-one
  参考文献：
  名称：

  [EN] TRI-SUBSTITUTED PYRIDINES
  [FR] PYRIDINES TRI-SUBSTITUÉES

  摘要：

  Described hereina re trisubstituted pyridine compounds compounds useful in the modulation of IL-12, IL-23 and/or IFNα by acting on TYK2 to cause signal transduction inhibition, as well as to pharmaceutical compositions containing the same and to methods of their use and preparation.

  公开号：

  WO2023064223A1
• 作为产物：
  描述：

  4-amino-1-(2-hydroxyethyl)pyrimidin-2-one 在 氯化亚砜 作用下， 以 吡啶 为溶剂， 以80%的产率得到1-(2-chloroethyl)cytosine
  参考文献：
  名称：

  Two simple protocols for the preparation of diallylaminoethyl-substituted nucleic bases: a comparison

  摘要：

  The syntheses of pyrimidine and purine nucleic bases substituted with diallylaminoethyl groups are reported following two different protocols. A comparison is made between the yield, expense, and difficulty of each route. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2006.01.035

文献信息

• Macrolides with antibacterial activity
  申请人：——

  公开号：US20030199459A1

  公开（公告）日：2003-10-23

  The invention provides new macrolides antibiotics of formula (I) with improved biological properties and improved stability formula (I): wherein R 1 is hydrogen, cyano, —S(L) m R 2 , —S(O)(L) m R 2 , or —S(O) 2 (L) m R 2 ; L represents —(CH 2 ) n — or —(CH 2 ) n Z(CH 2 ) n′ —-; m is 0 or 1; n is 1, 2, 3, or 4; n′ is 0, 1, 2, 3, or 4; Z is O, S or NH; R2 is hydrogen, alkyl, heterocyclyl or aryl; which heterocyclyl and the aryl groups may be further substituted; * indicates a chiral center which is in the (R) or (S) form and pharmaceutically acceptable acid addition salts or in vivo cleavable esters thereof. 1

  该发明提供了具有改进生物性能和改进稳定性的新大环内酯类抗生素的公式(I)：其中R1为氢、氰基、—S(L)mR2、—S(O)(L)mR2或—S(O)2(L)mR2；L代表—(CH2)n—或—(CH2)nZ(CH2)n′—；m为0或1；n为1、2、3或4；n′为0、1、2、3或4；Z为O、S或NH；R2为氢、烷基、杂环烷基或芳基；其中杂环烷基和芳基基团可能进一步取代；*表示手性中心，为(R)或(S)形式，以及其药学上可接受的酸盐或体内可水解酯。
• NEW MACROLIDES WITH ANTIBACTERIAL ACTIVITY
  申请人：Basilea Pharmaceutica AG

  公开号：EP1313751A1

  公开（公告）日：2003-05-28
• PROCESS FOR MANUFACTURING PURIFIED PHOSPHORODIAMIDITE
  申请人：ISIS PHARMACEUTICALS, INC.

  公开号：EP1492800A2

  公开（公告）日：2005-01-05
• US6740642B2
  申请人：——

  公开号：US6740642B2

  公开（公告）日：2004-05-25
• [EN] NEW MACROLIDES WITH ANTIBACTERIAL ACTIVITY<br/>[FR] NOUVEAUX MACROLIDES AVEC UNE ACTIVITE ANTIBACTERIENNE
  申请人：BASILEA PHARMACEUTICA AG

  公开号：WO2002016380A1

  公开（公告）日：2002-02-28

  The invention provides new macrolides antibiotics of formula (I) with improved biological properties and improved stability formula (I): wherein R1 is hydrogen, cyano, -S(L)¿mR?2, -S(O)(L)¿mR?2, or -S(O)¿2(L)mR?2; L represents -(CH¿2?)n- or -(CH2)nZ(CH2)n'-; m is 0 or 1; n is 1, 2, 3, or 4; n' is 0, 1, 2, 3, or 4; Z is O, S or NH; R2 is hydrogen, alkyl, heterocyclyl or aryl; which heterocyclyl and the aryl groups may be further substituted; * indicates a chiral center which is in the (R) or (S) form and pharmaceutically acceptable acid addition salts or in vivo cleavable esters thereof.